Surgery of persistent hyperinsulinaemic hypoglycaemia

Seminars in Neonatology

Volumn 8, Issue 3, 2003, Pages 259-265

  Lindley, Keith J ^a,b   Spitz, Lewis ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Hyperinsulinism; Hypoglycaemia; Management

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLOROTHIAZIDE; DIAZOXIDE; GLUCAGON; INSULIN; NIFEDIPINE; OCTREOTIDE; SOMATOSTATIN;

ALGORITHM; BILE DUCT INJURY; CHEMICAL ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FROZEN SECTION; GENE MUTATION; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; ILEUS; INSULIN RELEASE; INTESTINE OBSTRUCTION; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PHENOTYPE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROVOCATION TEST; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; WOUND INFECTION;

EID: 0042848552     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(03)00027-7     Document Type: Article

References (65)

1. Glaser B, Thornton P, Otonkoski T et al. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000;82:F79-86.
2. de Lonlay P, Fournet JC, Touati G et al. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 2002;161:37-48.
3. de Lonlay P, Touati G, Robert JJ et al. Persistent hyperinsulinaemic hypoglycaemia. Semin Neonatal 2002;7: 95-100.
4. Glaser B. Hyperinsulinism of the newborn. Semin Perinatol 2000;24:150-63.
5. Aynsley-Green A, Hussain K, Hall J et al. Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000;82:F98.
6. Turner RC, Johnson PC. Suppression of insulin release by fish-insulin-induced hypoglycaemia: with reference to the diagnosis of insulinomas. Lancet 1973;1:1483-5.
7. Aynsley-Green A, Polak JM, Bloom SR et al. Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child 1981;56:496-508.
8. Morris AA, Thekekara A, Wilks Z et al. Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. Arch Dis Child 1996;75:115-9.
9. Stanley CA, Baker L. The causes of neonatal hypoglycemia. N Engl J Med 1999;340:1200-1.
10. Saudubray JM, Nassogne MC, de Lonlay P et al. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatal 2002;7:3-15.
11. Saudubray JM, de Lonlay P, Touati G et al. Genetic hypoglycaemia in infancy and childhood: pathophysiology and diagnosis. J Inherit Metab Dis 2000;23:197-214.
12. Dunne MJ, Kane C, Shepherd RM et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997;336:703-6.
13. Kane C, Shepherd RM, Squires PE et al. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med 1996; 2:1344-7.
14. Aynsley-Green A, Dunne MJ, James RF et al. Ions and genes in persistent hyperinsulinaemic hypoglycaemia in infancy: a commentary on the implications for tailoring treatment to disease pathogenesis. J Pediatr Endocrinol Metab 1998; 11 (Suppl 1):121-9.
15. Dunne MJ, Shepherd RM, Cosgrove KE et al. Persistent hyperinsulinaemic hyperglycaemia of infancy-derived cells; implications for beta-cells that replicate in vitro. J Mol Endocrinol 2000;24:313-20.
16. Dunne MJ. Ions, genes and insulin release: from basic science to clinical disease. Based on the 1998 R. D. Lawrence lecture. Diabet Med 2000;17:91-104.
17. Dunne MJ, Cosgrove KE, Shepherd RM et al. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol Metab 1999;10:146-52.
18. Shepherd RM, Cosgrove KE, O'Brien RE et al. Hyperinsulinism of infancy: towards an understanding of unregulated insulin release. European network for research into hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000; 82:F87-97.
19. Bitner-Glindzicz M, Lindley KJ, Rutland P et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet 2000;26:56-60.
20. Otonkoski T, Ammala C, Huopio H et al. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 1999;48:408-15.
21. Thomas PM, Wohllk N, Huang E et al. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet 1996;59:510-8.
22. Thomas PM, Cote GJ, Wohllk N et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268:426-9.
23. Grimberg A, Ferry RJ Jr, Kelly A et al. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes 2001; 50:322-8.
24. Nestorowicz A, Inagaki N, Gonoi T et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 1997; 46:1743-8.
25. Nestorowicz A, Wilson BA, Schoor KP et al. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996; 5:1813-22.
26. Huopio H, Shyng SL, Otonkoski T et al. KATP channels and insulin secretion disorders. Am J Physiol 2002;283:E207-16.
27. Straub SG, Cosgrove KE, Ammala C et al. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways. Diabetes 2001;50:329-39.
28. Cartier EA, Conti LR, Vandenberg CA et al. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc Natl Acad Sci USA 2001;98:2882-7.
29. Partridge CJ, Beech DJ, Sivaprasadarao A. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familiar hyperinsulinism. J Biol Chem 2001; 276:35947-52.
30. Taschenberger G, Mougey A, Shen S et al. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal traffickin trafficking and function of KATP channels. J Biol Chem 2002;277:17139-46.
31. Kane C, Lindley KJ, Johnson PR et at. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin. J Clin Invest 1997;100:1888-93.
32. Huopio H, Reimann F, Ashfield R et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest 2000;106:897-906.
33. Stanley CA, Fang J, Kutyna K et al. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA contributing investigators. Diabetes 2000;49:667-73.
34. Stanley CA, Lieu YK, Hsu BY et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998; 338:1352-7.
35. Santer R, Kinner M, Passarge M et al. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet 2001;108:66-71.
36. de Lonlay P, Benetti C, Fouque F et al. Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients. Pediatr Res 2001;50:353-7.
37. Clayton PT, Eaton S, Aynsley-Green A et al. Hyperinsulinism in short-chain 1-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 2001;108:457-65.
38. Jaeken J, Matthijs G, Saudubray JM et al. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 1998;62:1535-9.
39. Glaser B, Kesavan P, Heyman M et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998;338:226-30.
40. Rahier J, Sempoux C, Fournet JC et al. Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology 1998; 32:15-9.
41. Sempoux C, Poggi F, Brunelle F et at. Nesidioblastosis and persistent neonatal hyperinsulinism. Diabetes Metab 1995; 21:402-7.
42. de Lonlay P, Fournet JC, Rahier J et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997;100:802-7.
43. Fournet JC, Verkarre V, de Lonlay P et al. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia. Ann Endocrinol (Paris) 1998;59:485-91.
44. Fournet JC, Mayaud C, de Lonlay P et al. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 2001;158:2177-84.
45. Fournet JC, Mayaud C, de Lonlay P et al. Loss of imprinted genes and paternal SUR1 mutations lead to focal form of congenital hyperinsulinism. Horm Res 2000;53(Suppl 1): 2-6.
46. Verkarre V, Fournet JC, de Lonlay P et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998; 102:1286-91.
47. Lonlay-Debeney P, Poggi-Travert F, Fournet JC et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999;340:1169-75.
48. Smith VV, Malone M, Risdon RA. Focal or diffuse lesions in persistent hyperinsulinemic hypoglycemia of infancy: concerns about interpretation of intraoperative frozen sections. Pediatr Dev Pathol 2001;4:138-43.
49. Cretolle C, Fekete CN, Jan D et al. Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: a report of 45 cases from 1983 to 2000. J Pediatr Surg 2002;37:155-8.
50. Leibowitz G, Glaser B, Higazi AA et al. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 1995;80:386-92.
51. Labrune P, Lechevallier S, Rautt M et al. Diabetes mellitus 14 years after subtotal pancreatectomy for neonatal hypednsulinism. J Pediatr Surg 1990;25:1246-7.
52. Dubois J, Brunelle F, Touati G et al. Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25:512-6.
53. Brunelle F, Negre V, Barth MO et al. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989;19:100-3.
54. Chigot V, de Lontay P, Nassogne MC et al. Pancreatic arterial calcium stimulation in the diagnosis and localisation of persistent hyperinsulinemic hypoglycaemia of infancy. Pediatr Radiol 2001;31:650-5.
55. Abernethy LJ, Davidson DC, Lamont GL et al. Intra-arteriat calcium stimulation test in the investigation of hyperinsulinaemic hypoglycaemia. Arch Dis Child 1998; 78:359-63.
56. Ferry RJ Jr, Kelly A, Grimberg A et al. Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism. J Pediatr 2000;137:239-46.
57. Touati G, Poggi-Travert F, Ogier DB et al. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 1998;157:628-33.
58. Lindley KJ, Dunne MJ, Kane C et al. Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child 1996;74:373-8.
59. Bas F, Darendeliler F, Demirkol D et al. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab 1999;12:873-8.
60. Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 1993;123:644-50.
61. Thornton PS, Alter CA, Katz LE et al. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr 1993;123:637-43.
62. Wilson DC, Carson DJ, Quinn RJ. Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis. Acta Paediatr Scand 1988; 77:467-70.
63. Dunger DB, Burns C, Ghale GK et al. Pancreatic exocrine and endocrine function after subtotal pancreatectomy for nesidioblastosis. J Pediatr Surg 1988;23:112-5.
64. Spitz L. Surgery for hyperinsulinaemic hypoglycaemia. In: Spitz L, Coran AG, editors. Pediatric surgery. London: Chapman and Hall Medical 1995;618-22.
65. McAndrew HF, Smith V, Spitz L. Surgical complications of pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy. J Pediatr Surg 2003;38:13-6.